Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-Reactivity

NCT06617312 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT06617312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06617312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-Reactivity
Lead sponsor
University of California, Los Angeles
Phase
Phase 2
Overall status
Recruiting
Start date
December 5, 2024
Completion date
December 31, 2026
Enrollment
64 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation, tobacco use disorder